Humira Pricing Takes Center Stage In Dutch Courts

AbbVie To Battle Human Rights Court Case

A public interest group has accused the pharma major of using excessive pricing to bolster sales of blockbuster Humira, consequently damaging the health of Dutch patients. 

Human rights
• Source: Shutterstock

Did AbbVie Inc. violate human rights with its pricing for a best-selling medicine?

A Dutch court recently agreed to decide the question, which was raised in a lawsuit by a public interest group...

More from Market Access

More from In Vivo